 |
This survey was conducted in 2022 among staff working at sites conducting clinical trials who had worked on partially or fully decentralized clinical trials during the preceding 12 months. The study’s objectives were to gain insights into the experiences clinical trial sites have had in conducting decentralized trials, including their practices, vendors, views of the benefits, challenges faced, and satisfaction with the solutions offered. The data obtained here supplement the findings of surveys conducted by PPD in 2020 and 2021 that examined similar issues from the perspective of sponsor pharma companies rather than sites. |
